CFM
INSM icon

Catalyst Funds Management’s Insmed INSM Stock Holding History

Catalyst Funds Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.79M Buy
+26,200
New +$3.17M 0.16% 149
2025
Q4 		– Sell
-47,900
Closed -$6.9M – 453
2025
Q3 		$6.9M Buy
47,900
+725
+2% +$88.8K 1.04% 17
2025
Q2 		$4.75M Buy
+47,175
New +$3.61M 1.31% 10
2025
Q1 		– Sell
-11,250
Closed -$777K – 522
2024
Q4 		$777K Buy
11,250
+4,250
+61% +$306K 0.19% 110
2024
Q3 		$511K Buy
+7,000
New +$517K 0.11% 131
2024
Q2 		– Sell
-1,600
Closed -$43.4K – 1364
2024
Q1 		$43.4K Buy
+1,600
New +$44.8K 0.01% 597

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Catalyst Funds Management's INSM Position: Q2 2026 in Review

Catalyst Funds Management opened a new position in Insmed (INSM) in Q2 2026: 26,200 shares worth $2.79M. The stake represents 0.16% of the portfolio and ranks #149 among its holdings. This is a return to the name: Catalyst Funds Management previously reported a position in INSM as recently as Q3 2025.

Catalyst Funds Management first reported a position in INSM in Q1 2024 and has held it in 6 quarters since. The position peaked at $6.9M in Q3 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Catalyst Funds Management held 26,200 shares of Insmed worth $2.79M as of Q2 2026.
  • Insmed was a new Catalyst Funds Management position in Q2 2026.
  • Insmed made up 0.16% of Catalyst Funds Management's portfolio in Q2 2026, its #149 holding.
  • Catalyst Funds Management first reported a position in Insmed in Q1 2024 and has held it in 6 quarters since.
  • Catalyst Funds Management's Insmed position peaked at $6.9M in Q3 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.